Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's disease.
Regev S, Schwartz D, Sarid O, Goren G, Slonim-Nevo V, Friger M, Sergienko R, Greenberg D, Monsonego A, Nemirovsky A, Odes S. Regev S, et al. Among authors: monsonego a. Aliment Pharmacol Ther. 2023 Apr;57(8):861-871. doi: 10.1111/apt.17399. Epub 2023 Feb 2. Aliment Pharmacol Ther. 2023. PMID: 36734040 Clinical Trial.
Correction: Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
Verma A, Shteinfer-Kuzmine A, Kamenetsky N, Pittala S, Paul A, Nahon Crystal E, Ouro A, Chalifa-Caspi V, Pandey SK, Monsonego A, Vardi N, Knafo S, Shoshan-Barmatz V. Verma A, et al. Among authors: monsonego a. Transl Neurodegener. 2023 Jan 11;12(1):2. doi: 10.1186/s40035-023-00335-3. Transl Neurodegener. 2023. PMID: 36627723 Free PMC article. No abstract available.
Targeting the overexpressed mitochondrial protein VDAC1 in a mouse model of Alzheimer's disease protects against mitochondrial dysfunction and mitigates brain pathology.
Verma A, Shteinfer-Kuzmine A, Kamenetsky N, Pittala S, Paul A, Nahon Crystal E, Ouro A, Chalifa-Caspi V, Pandey SK, Monsonego A, Vardi N, Knafo S, Shoshan-Barmatz V. Verma A, et al. Among authors: monsonego a. Transl Neurodegener. 2022 Dec 28;11(1):58. doi: 10.1186/s40035-022-00329-7. Transl Neurodegener. 2022. PMID: 36578022 Free PMC article.
Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age.
Zuroff L, Rezk A, Shinoda K, Espinoza DA, Elyahu Y, Zhang B, Chen AA, Shinohara RT, Jacobs D, Alcalay RN, Tropea TF, Chen-Plotkin A, Monsonego A, Li R, Bar-Or A. Zuroff L, et al. Among authors: monsonego a. EBioMedicine. 2022 Aug;82:104179. doi: 10.1016/j.ebiom.2022.104179. Epub 2022 Jul 19. EBioMedicine. 2022. PMID: 35868128 Free PMC article.
Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease.
Nemirovsky A, Ilan K, Lerner L, Cohen-Lavi L, Schwartz D, Goren G, Sergienko R, Greenberg D, Slonim-Nevo V, Sarid O, Friger M, Regev S, Odes S, Hertz T, Monsonego A; Israeli IBD Research Nucleus (IIRN). Nemirovsky A, et al. Among authors: monsonego a. Brain Behav Immun Health. 2021 Dec 23;19:100407. doi: 10.1016/j.bbih.2021.100407. eCollection 2022 Feb. Brain Behav Immun Health. 2021. PMID: 35024638 Free PMC article.
Parp1 promotes sleep, which enhances DNA repair in neurons.
Zada D, Sela Y, Matosevich N, Monsonego A, Lerer-Goldshtein T, Nir Y, Appelbaum L. Zada D, et al. Among authors: monsonego a. Mol Cell. 2021 Dec 16;81(24):4979-4993.e7. doi: 10.1016/j.molcel.2021.10.026. Epub 2021 Nov 18. Mol Cell. 2021. PMID: 34798058 Free PMC article.
59 results